Cardiovascular Effects of Incretin Therapy in Diabetes Care

Metabolic Syndrome and Related Disorders - United States
doi 10.1089/met.2014.0035
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Mary Ann Liebert Inc

Related search

Cardiovascular Effects of the Incretin-Based Therapy: The Good, the Bad, or the Ugly?

Journal of Diabetes Investigation
Internal MedicineEndocrinologyMetabolismMedicineDiabetes
2015English

Which Incretin-Based Therapy for Type 2 Diabetes?

The Lancet
Medicine
2014English

Correction: Cardiovascular Effect of Incretin-Based Therapy in Patients With Type 2 Diabetes Mellitus: Systematic Review and Meta-Analysis

PLoS ONE
Multidisciplinary
2018English

Role of Incretin‐based Therapy in Hospitalized Patients With Type 2 Diabetes

Journal of Diabetes Investigation
Internal MedicineEndocrinologyMetabolismMedicineDiabetes
2019English

Cardiovascular Effects of Incretin-Based Therapies in Patients With Type 2 Diabetes: A Systematic Review and Network Meta-Analysis

The Lancet Diabetes and Endocrinology
Internal MedicineEndocrinologyMetabolismDiabetes
2016English

Effects of Diabetes Medications Targeting the Incretin System on the Kidney

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2018English

Metabolic Effects of the Incretin Mimetic Exenatide in the Treatment of Type 2 Diabetes

Vascular Health and Risk Management
PharmacologyCardiologyEndocrinologyPublic HealthHematologyEnvironmentalCardiovascular MedicineMedicineOccupational HealthMetabolismDiabetes
2006English

Incretin-Based Therapy: A Powerful and Promising Weapon in the Treatment of Type 2 Diabetes Mellitus

Diabetes Therapy
Internal MedicineEndocrinologyMetabolismDiabetes
2011English

Predicting Response to Incretin-Based Therapy

Research and Reports in Endocrine Disorders
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy